These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27878521)

  • 21. Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.
    Boyd A; Maylin S; Moh R; Mahjoub N; Gabillard D; Eholié SP; Danel C; Anglaret X; Zoulim F; Girard PM; Delaugerre C; Lacombefor K;
    J Gastroenterol Hepatol; 2016 Mar; 31(3):634-44. PubMed ID: 26313291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
    Sanders RC; Lewis D; Dyke T; Alpers MP
    P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-label time-resolved fluoroimmunoassay for simultaneous detection of aflatoxin B1 and ochratoxin A.
    Huang B; Xiao H; Zhang J; Zhang L; Yang H; Zhang Y; Jin J
    Arch Toxicol; 2009 Jun; 83(6):619-24. PubMed ID: 19252900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological detection of hepatitis B viral infection by a panel of solid-phase enzyme-linked immunosorbent assays (ELISA).
    Tsitsilonis OE; Thrasyvoulides A; Balafas A; Voutsas JF; Papamichail M; Lymberi P
    J Pharm Biomed Anal; 2004 Mar; 34(4):811-22. PubMed ID: 15019059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA; Stramer SL; Kuhns MC; Schlauder GG
    Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel method for sensitive, low-cost and portable detection of hepatitis B surface antigen using a personal glucose meter.
    Taebi S; Keyhanfar M; Noorbakhsh A
    J Immunol Methods; 2018 Jul; 458():26-32. PubMed ID: 29654816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The development of dual-label time-resolved fluorescence immunoassay (TRFIA) for screening of ovarian cancer based on simultaneous detection of human epididymis protein-4 and cancer antigen 125.
    Sun WQ; Wang Y; Liu XZ; Li LQ; Chen CC; Zhang LC
    J Immunoassay Immunochem; 2016; 37(5):453-62. PubMed ID: 26926833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of pH-sensitive immobilized monoclonal antibodies for optimization of immunoenzyme sandwich technique of detection of HBsAg of hepatitis B virus].
    Iakovleva DA; Dmitriev AD; Dmitriev DA; Koliaskina GI; Massino IuS; Pavlova EV; Pyrenkova IIu; Smirnova MB; Segal OL; Tarakanova IuN; Ulanova TI; Fartushnaia ON; Sharipova IN; Koliaskina GI; Lavrov VF
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):85-9. PubMed ID: 20468098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the highly sensitive chemiluminescent enzyme immunoassay "Lumipulse HBsAg-HQ" for hepatitis B virus screening.
    Deguchi M; Kagita M; Yoshioka N; Tsukamoto H; Takao M; Tahara K; Maeda I; Hidaka Y; Yamauchi S; Kaneko A; Miyakoshi H; Isomura M
    J Clin Lab Anal; 2018 May; 32(4):e22334. PubMed ID: 28984383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A rapid immunochromatographic assay for hepatitis B virus screening.
    Lau DT; Ma H; Lemon SM; Doo E; Ghany MG; Miskovsky E; Woods GL; Park Y; Hoofnagle JH
    J Viral Hepat; 2003 Jul; 10(4):331-4. PubMed ID: 12823602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual-label time-resolved fluoroimmunoassay for simultaneous detection of myoglobin and carbonic anhydrase III in serum.
    Vuori J; Rasi S; Takala T; Väänänen K
    Clin Chem; 1991 Dec; 37(12):2087-92. PubMed ID: 1764784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of hepatitis B surface and "e" antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV.
    Boyd A; Maylin S; Gozlan J; Delaugerre C; Simon F; Girard PM; Lacombe K
    Liver Int; 2015 Mar; 35(3):795-804. PubMed ID: 24606220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upconverting nanoparticle reporter-based highly sensitive rapid lateral flow immunoassay for hepatitis B virus surface antigen.
    Martiskainen I; Talha SM; Vuorenpää K; Salminen T; Juntunen E; Chattopadhyay S; Kumar D; Vuorinen T; Pettersson K; Khanna N; Batra G
    Anal Bioanal Chem; 2021 Feb; 413(4):967-978. PubMed ID: 33230700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients.
    Mitsumoto F; Murata M; Ura K; Takayama K; Hiramine S; Shimizu M; Toyoda K; Ogawa E; Furusyo N; Hayashi J
    J Infect Chemother; 2015 Apr; 21(4):264-71. PubMed ID: 25596071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of hepatitis B surface antigen and E antigen: correlation between Elecsys and architect assays.
    Zhou B; Liu M; Lv G; Zheng H; Wang Y; Sun J; Hou J
    J Viral Hepat; 2013 Jun; 20(6):422-9. PubMed ID: 23647959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence of hepatitis B virus serological markers among pregnant Nigerian women.
    Aba HO; Aminu M
    Ann Afr Med; 2016; 15(1):20-7. PubMed ID: 26857933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new method for screening acute/chronic lymphocytic leukemia: dual-label time-resolved fluorescence immunoassay.
    Zhang Z; Zhang J; Dai S; Xu H
    BMC Biotechnol; 2022 Sep; 22(1):27. PubMed ID: 36180909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilution.
    Liu TW; Yeh ML; Huang CF; Lin IL; Huang JF; Dai CY; Chen YL; Chuang WL; Yu ML
    Kaohsiung J Med Sci; 2015 Jan; 31(1):26-33. PubMed ID: 25600917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-center evaluation of the hepatitis B surface antigen (HBsAg) assay and HbsAg confirmatory assay for the family of Access immunoassay systems.
    Lunel-Fabiani F; Duburcq X; Levayer T; Descamps F; Maniez-Montreuil M; Pivert A; Ducancelle A; Pouzet A; Marant L; Clèment A; Duhamel D; Leirens Y; Margotteau F; Falcou-Briatte R; Heinen C; Bouniort F; Taskar S; Artus A; Woodrum D; Flecheux O
    Clin Lab; 2010; 56(7-8):281-90. PubMed ID: 20857892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.